ECM
LLY icon

Evergreen Capital Management’s Eli Lilly LLY Stock Holding History

Evergreen Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– -$6.53M – 1618
2026
Q1 		– Hold
0
– – – 154
2025
Q4 		– Hold
0
– -$763K – 1476
2025
Q3 		– Hold
0
– – – 476

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evergreen Capital Management's LLY Position: Q2 2026 in Review

Evergreen Capital Management reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $3.95M and leaving 12,152 shares worth $14.6M. The position accounts for 0.26% of the portfolio, ranked #87.

Evergreen Capital Management first reported a position in LLY in Q2 2018 and has held it in 33 quarters since. The position peaked at $14.7M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Evergreen Capital Management held 12,152 shares of Eli Lilly worth $14.6M as of Q2 2026.
  • Evergreen Capital Management sold 3,868 Eli Lilly shares in Q2 2026, an estimated $3.95M.
  • Eli Lilly made up 0.26% of Evergreen Capital Management's portfolio in Q2 2026, its #87 holding.
  • Evergreen Capital Management first reported a position in Eli Lilly in Q2 2018 and has held it in 33 quarters since.
  • Evergreen Capital Management's Eli Lilly position peaked at $14.7M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.